Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference34 articles.
1. Ferrario, A., Kanavos, P.: Managed entry agreements for pharmaceuticals: the European experience. EMiNet, Brussels (2013)
2. Klemp, M., Frønsdal, K., Facey, K., et al.: What principles should govern the use of managed entry agreements? Int. J. Technol. Assess. Health Care 27, 77–83 (2011)
3. Ferrario, A., Kanavos, P.: Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Soc. Sci. Med. 124, 39–47 (2014)
4. Sorenson, C., Drummond, D., Torbica, A., et al.: The role of hospital payments in the adoption of new medical technologies: an international survey of current practice. Health Econ. Policy Law 17, 1–27 (2014)
5. Nhs England: The cancer drugs fund. https://www.england.nhs.uk/cancer/cdf/ (2014). Accessed 15 Nov 2014
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献